Claris Ventures SGR SpA makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.
We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas.
We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence.
Location: Italy, Piemont, Turin
Employees: 1-10
Founded date: 2019
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 22.02.2023 | Resalis Th... | resalisthe... | $28.67M | Italy, Pie... |
| 15.03.2021 | NeoPhore | neophore.c... | $32.49M | United Kin... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 09.03.2021 | NeoPhore Announces £15.2m Financing to Advance DNA Mismatch ... | Round led by Claris Ventures with 2Invest, 3B Future Health Fund and Astellas Venture Management ... | 3bfuturehe... |
| 02.09.2020 | Claris Ventures Holds First Close of Maiden Fund, at $30M | Claris Ventures, a Turin, Italy-based newly formed venture capital firm, announced the first closing... | finsmes.co... |